A Clinical Study to Assess the Efficacy and Safety of SED80 for Use in Cataract Surgery
Status:
Completed
Trial end date:
2020-11-15
Target enrollment:
Participant gender:
Summary
Patients at least 40 years of age who are undergoing cataract surgery will be randomized to
receive treatment with one of four groups of dexamethasone ophthalmic suspension or placebo
eye drops to determine if the drops decrease inflammation and pain inside the eye and are
safe after cataract surgery.